drugset / Trial / NCT01472432
DPP IV Inhibition Facilitates Healing of Chronic Foot Ulcers in Type 2 Diabetes
RandomizedParallel-groupDouble-blindTreatment
Summary
A randomized versus placebo trial designed to evaluate the clinical and humoral effects of 4 months of vildagliptin on healing of chronic ulcers in type 2 diabetes.
Timeline
- Start
- 2011-05
- Primary completion
- 2016-01
- Completion
- 2016-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vildagliptin | Other / unclassified | 50 mg | Oral |